Dermatology Department, University Hospital and Faculty of Medicine of the University of Zürich, Zürich, Switzerland.
J Invest Dermatol. 2018 Nov;138(11):2304-2306. doi: 10.1016/j.jid.2018.06.177. Epub 2018 Aug 28.
Acne vulgaris is treated with antibiotics and retinoids, but side effects are numerous. Novel safe and efficient therapies are still needed. Wang et al. demonstrate that the secreted virulence factor Christie-Atkins-Munch-Peterson factor 2 from Propionibacterium acnes, a bacterium involved in acne pathogenesis, promotes inflammatory responses. This proinflammatory property could be inhibited by antibodies to Christie-Atkins-Munch-Peterson factor 2, suggesting Christie-Atkins-Munch-Peterson factor 2 as a candidate target in acne vaccination. This work supports the concept of acne immunotherapy, but questions about selection of target antigens remain open.
寻常痤疮采用抗生素和维 A 酸治疗,但副作用众多。仍需要新型安全有效的治疗方法。Wang 等人证明,痤疮发病机制相关细菌痤疮丙酸杆菌分泌的毒力因子 Christie-Atkins-Munch-Peterson 因子 2 可促进炎症反应。Christie-Atkins-Munch-Peterson 因子 2 的抗体可抑制这种促炎作用,提示 Christie-Atkins-Munch-Peterson 因子 2 可能成为痤疮疫苗的候选靶点。该研究支持痤疮免疫治疗的概念,但关于靶抗原的选择仍存在疑问。